Moreover, hyperinsulinemia can elevate circulating levels of free insulin-like growth factor 1 (IGF-1) by reducing hepatic production of IGF-1 binding proteins 1 and 2, thereby further enhancing tumor growth and proliferation [106]. Here, IGF1 is linked to hyperinsulinism.